在没有DICOM数据传输的情况下开发基于GUI的简单独立剂量计算软件,用于高剂量率支臂治疗
Yuha Kim1, Yang Sheng2, Chunhao Wang2
1Panther Creek High School, Cary, North Carolina, USA.
Journal of contemporary brachytherapy
|February 13, 2025
概括
这项研究开发了用户友好的软件,用于在高剂量率胸膜疗法中独立验证剂量计算. 该软件确保准确性,符合放射治疗治疗计划的临床指南.
科学领域:
- 医学物理 医学物理
- 辐射瘤学 辐射瘤学
- 软件开发 软件开发
背景情况:
- 在进行放射治疗之前,独立的剂量计算验证对于临床治疗计划至关重要.
- 现有的验证方法可能缺乏效率或广泛的系统兼容性.
- 高剂量率 (HDR) 支臂治疗需要精确和及时的剂量计算.
研究的目的:
- 开发和介绍一个独立的,用户友好的软件,用于在临床HDR支架治疗中进行第二次检查剂量计算.
- 确保软件符合既定的临床指南,并提供准确的剂量验证.
主要方法:
- 在Google Colab上使用Python 3开发软件,可在标准计算机上部署.
- 使用AAPM TG-43形式主义和共识数据集来计算剂量.
- 对商业治疗计划系统 (Varian Brachy-Vision) 进行了验证,使用了117个临床HDR支臂治疗计划 (妇科和IORT病例).
主要成果:
- 与治疗计划系统相比,软件计算的剂量显示平均差异为-1%±0.36%,相当于AAPM指南 (<5%偏差).
- 该软件的图形用户界面 (GUI) 简化了输入和操作,不需要额外的软件或手动数据输入.
- 在手术内进行放射治疗 (IORT) 的特别优势需要快速的离线验证.
结论:
- 通过使用TG-43形式主义,成功开发了一种简单可执行的GUI软件,用于HDR臂疗剂量验证.
- 该软件准确,符合临床实践指南,兼容Windows,MacOS和Linux系统.
- 该软件将公开提供,提高在放射瘤学的独立剂量验证的可访问性.
相关概念视频
Radiation: Applications
1.8K
The average temperature of Earth is the subject of much current discussion. Earth is in radiative contact with both the Sun and dark space; it receives almost all its energy from the radiation of the Sun and reflects some of it into outer space. Dark space is very cold, about 3 K, so Earth radiates energy into it. For instance, heat transfer occurs from soil and grasses, the rate of which can be so rapid that frost can occur on clear summer evenings, even in warm latitudes.
The average...
The average...
1.8K
Dosage Regimens: Designs and Approaches
597
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
597
Dosage Regimen: Individualization
388
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
388
Dosage Regimen Designs: Nomograms and Tabulations
351
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
351
Dose Size and Dosing Frequency: Determination Methods
797
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
797
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
394
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
394


